The first simultaneous publication from #ISNWCN
journals.lww.com/jasn/fulltex... in @asnpublications.bsky.social JASN
Atrasentan reduced proteinuria in IgAN even if on RASi + Flozin
journals.lww.com/jasn/fulltex... in @asnpublications.bsky.social JASN
Atrasentan reduced proteinuria in IgAN even if on RASi + Flozin
March 29, 2026 at 5:22 AM
The first simultaneous publication from #ISNWCN
journals.lww.com/jasn/fulltex... in @asnpublications.bsky.social JASN
Atrasentan reduced proteinuria in IgAN even if on RASi + Flozin
journals.lww.com/jasn/fulltex... in @asnpublications.bsky.social JASN
Atrasentan reduced proteinuria in IgAN even if on RASi + Flozin
I swear...Jasn 6th will look like kindergarten once these ICE criminals are brought to justice...
August 24, 2025 at 5:26 AM
I swear...Jasn 6th will look like kindergarten once these ICE criminals are brought to justice...
Clazakizumab, an IL-6 inhibitor, improves iron metabolism & may reduce ESA use in dialysis
✅ ↓ Hepcidin (~44%)
✅ ↑ TSAT (up to 19%)
✅ ↓ ESA dose uptitration
P3 trial (n=2,200) ongoing for CV outcomes.
Our findings now in JASN @asnpublications.bsky.social : journals.lww.com/jasn/citatio...
✅ ↓ Hepcidin (~44%)
✅ ↑ TSAT (up to 19%)
✅ ↓ ESA dose uptitration
P3 trial (n=2,200) ongoing for CV outcomes.
Our findings now in JASN @asnpublications.bsky.social : journals.lww.com/jasn/citatio...
February 9, 2025 at 11:10 AM
Clazakizumab, an IL-6 inhibitor, improves iron metabolism & may reduce ESA use in dialysis
✅ ↓ Hepcidin (~44%)
✅ ↑ TSAT (up to 19%)
✅ ↓ ESA dose uptitration
P3 trial (n=2,200) ongoing for CV outcomes.
Our findings now in JASN @asnpublications.bsky.social : journals.lww.com/jasn/citatio...
✅ ↓ Hepcidin (~44%)
✅ ↑ TSAT (up to 19%)
✅ ↓ ESA dose uptitration
P3 trial (n=2,200) ongoing for CV outcomes.
Our findings now in JASN @asnpublications.bsky.social : journals.lww.com/jasn/citatio...
Jelka.
Pa kaj ti ni jasn!
Pa kaj ti ni jasn!
November 17, 2025 at 2:11 PM
Jelka.
Pa kaj ti ni jasn!
Pa kaj ti ni jasn!
Jasn, že jde. V remosce se dá udělat všechno.
July 21, 2025 at 11:19 AM
Jasn, že jde. V remosce se dá udělat všechno.
Kako ljubljanskega harmonikarja še ni pograbil Duracell, mi pa tud ni jasn.
June 5, 2025 at 7:56 PM
Kako ljubljanskega harmonikarja še ni pograbil Duracell, mi pa tud ni jasn.
glupi otročički, ki jim nič ni jasn.
March 14, 2026 at 3:05 PM
glupi otročički, ki jim nič ni jasn.
The April issue of JASN is now available online! Topics covered this month include:
- Novel Therapies for IgA Nephropathy
- Rituximab in Podocytopathies
- and more
Find the issue here: journals.lww.com/jas...
#ASNJASN
- Novel Therapies for IgA Nephropathy
- Rituximab in Podocytopathies
- and more
Find the issue here: journals.lww.com/jas...
#ASNJASN
April 1, 2025 at 4:30 PM
The April issue of JASN is now available online! Topics covered this month include:
- Novel Therapies for IgA Nephropathy
- Rituximab in Podocytopathies
- and more
Find the issue here: journals.lww.com/jas...
#ASNJASN
- Novel Therapies for IgA Nephropathy
- Rituximab in Podocytopathies
- and more
Find the issue here: journals.lww.com/jas...
#ASNJASN
Another LBCT simultaneous pub at #ISNWCN
A CONFIDENCE mediation analysis in @asnpublications.bsky.social #JASN
journals.lww.com/jasn/fulltex...
VA by @edgarvlermamd.bsky.social
A CONFIDENCE mediation analysis in @asnpublications.bsky.social #JASN
journals.lww.com/jasn/fulltex...
VA by @edgarvlermamd.bsky.social
March 30, 2026 at 1:35 AM
Another LBCT simultaneous pub at #ISNWCN
A CONFIDENCE mediation analysis in @asnpublications.bsky.social #JASN
journals.lww.com/jasn/fulltex...
VA by @edgarvlermamd.bsky.social
A CONFIDENCE mediation analysis in @asnpublications.bsky.social #JASN
journals.lww.com/jasn/fulltex...
VA by @edgarvlermamd.bsky.social
DOBR, PA KA TEB NI JASN, NO!
July 28, 2026 at 1:58 PM
DOBR, PA KA TEB NI JASN, NO!
Freshly published in JASN!
Read our perspective on #APOL1 kidney risk variants and their implications, based on the recent H3Africa publication in the NEJM
@opeyemiolabisi.bsky.social @gbadegesinlab.bsky.social
journals.lww.com/jasn/citatio...
www-nejm-org.ezproxy.cul.columbia.edu/doi/10.1056/...
Read our perspective on #APOL1 kidney risk variants and their implications, based on the recent H3Africa publication in the NEJM
@opeyemiolabisi.bsky.social @gbadegesinlab.bsky.social
journals.lww.com/jasn/citatio...
www-nejm-org.ezproxy.cul.columbia.edu/doi/10.1056/...
Prevalence and Impact of APOL1 Kidney Risk Variants in West ... : Journal of the American Society of Nephrology
An abstract is unavailable. This article is available as a PDF only.
journals.lww.com
November 27, 2024 at 10:35 PM
Freshly published in JASN!
Read our perspective on #APOL1 kidney risk variants and their implications, based on the recent H3Africa publication in the NEJM
@opeyemiolabisi.bsky.social @gbadegesinlab.bsky.social
journals.lww.com/jasn/citatio...
www-nejm-org.ezproxy.cul.columbia.edu/doi/10.1056/...
Read our perspective on #APOL1 kidney risk variants and their implications, based on the recent H3Africa publication in the NEJM
@opeyemiolabisi.bsky.social @gbadegesinlab.bsky.social
journals.lww.com/jasn/citatio...
www-nejm-org.ezproxy.cul.columbia.edu/doi/10.1056/...
Po dopustih so bolniške, kaj kle ni jasn?!?
July 22, 2026 at 3:22 PM
Po dopustih so bolniške, kaj kle ni jasn?!?
Interesting paper @asnpublications.bsky.social
SGLT2 inhibitors prevent kidney magnesium loss caused by cisplatin
#flozins improve Mg reabsorption in the thick ascending limb and distal convoluted tubule
VA by @corinateodosiu.bsky.social
#nephsky #medsky
journals.lww.com/jasn/abstrac...
SGLT2 inhibitors prevent kidney magnesium loss caused by cisplatin
#flozins improve Mg reabsorption in the thick ascending limb and distal convoluted tubule
VA by @corinateodosiu.bsky.social
#nephsky #medsky
journals.lww.com/jasn/abstrac...
April 3, 2025 at 9:57 AM
Interesting paper @asnpublications.bsky.social
SGLT2 inhibitors prevent kidney magnesium loss caused by cisplatin
#flozins improve Mg reabsorption in the thick ascending limb and distal convoluted tubule
VA by @corinateodosiu.bsky.social
#nephsky #medsky
journals.lww.com/jasn/abstrac...
SGLT2 inhibitors prevent kidney magnesium loss caused by cisplatin
#flozins improve Mg reabsorption in the thick ascending limb and distal convoluted tubule
VA by @corinateodosiu.bsky.social
#nephsky #medsky
journals.lww.com/jasn/abstrac...
Happy to share our paper in @asnpublications.bsky.social examining COL4A5 X-linked Alport Syndrome in an unselected health system-based population. Phenotypic spectrum of X-linked Alport syndrome is wider than previously known. Risk lower for Gly624Asp variant. 1/ journals.lww.com/jasn/fulltex...
January 3, 2025 at 2:33 PM
Happy to share our paper in @asnpublications.bsky.social examining COL4A5 X-linked Alport Syndrome in an unselected health system-based population. Phenotypic spectrum of X-linked Alport syndrome is wider than previously known. Risk lower for Gly624Asp variant. 1/ journals.lww.com/jasn/fulltex...
I encourage #nephsky folks to read the ASN Kidney Health Guidance on Obesity in CKD. ASN encourages nephs to understand tools available to help adults with obesity and CKD safely lose weight - hope its helpful journals.lww.com/jasn/fulltex...
accompanying podcast www.asn-online.org/media/podcas...
accompanying podcast www.asn-online.org/media/podcas...
November 10, 2024 at 3:03 AM
I encourage #nephsky folks to read the ASN Kidney Health Guidance on Obesity in CKD. ASN encourages nephs to understand tools available to help adults with obesity and CKD safely lose weight - hope its helpful journals.lww.com/jasn/fulltex...
accompanying podcast www.asn-online.org/media/podcas...
accompanying podcast www.asn-online.org/media/podcas...
The discovery of the #aquaporin #AQP family of water channels has provided a molecular counterpart to the movement of water across biological membranes. This JASN review, discusses the concept of osmosis and its central relevance for #PeritonealDialysis. journals.lww.com/jasn/fulltex...
Aquaporin-1 and Osmosis: From Physiology to Precision in... : Journal of the American Society of Nephrology
ion and/or trafficking are key to sustain osmosis in multiple tissues. Here, we review the convergent evidence demonstrating that aquaporin-1 (AQP1) facilitates water transport across endothelial cell...
journals.lww.com
November 10, 2024 at 3:00 PM
The discovery of the #aquaporin #AQP family of water channels has provided a molecular counterpart to the movement of water across biological membranes. This JASN review, discusses the concept of osmosis and its central relevance for #PeritonealDialysis. journals.lww.com/jasn/fulltex...
Pa dobr pa ka teb ni jasn no! 😂
September 15, 2026 at 12:15 PM
Pa dobr pa ka teb ni jasn no! 😂
Zate je pa res jasn :D
December 8, 2025 at 5:03 PM
Zate je pa res jasn :D
Editorial just published on Inflammation and Cyst Expansion in Polycystic Kidney Disease in JASN (@asnpublications.bsky.social) out of the Cantley lab — Drs. Vijay Kakade and Lloyd Cantley!!
🔗👇
journals.lww.com/jasn/citatio...
🔗👇
journals.lww.com/jasn/citatio...
journals.lww.com
October 7, 2025 at 2:20 AM
Editorial just published on Inflammation and Cyst Expansion in Polycystic Kidney Disease in JASN (@asnpublications.bsky.social) out of the Cantley lab — Drs. Vijay Kakade and Lloyd Cantley!!
🔗👇
journals.lww.com/jasn/citatio...
🔗👇
journals.lww.com/jasn/citatio...
How common is kidney failure with MCD and FSGS?
More than we think … @brianrifkin.bsky.social breaks down the recent @asnpublications.bsky.social JASN paper from the RaDaR study www.nephjc.com/news/nephjc-...
More than we think … @brianrifkin.bsky.social breaks down the recent @asnpublications.bsky.social JASN paper from the RaDaR study www.nephjc.com/news/nephjc-...
September 5, 2025 at 8:30 PM
How common is kidney failure with MCD and FSGS?
More than we think … @brianrifkin.bsky.social breaks down the recent @asnpublications.bsky.social JASN paper from the RaDaR study www.nephjc.com/news/nephjc-...
More than we think … @brianrifkin.bsky.social breaks down the recent @asnpublications.bsky.social JASN paper from the RaDaR study www.nephjc.com/news/nephjc-...
The February issue of JASN is now available online! Topics covered this month include:
- Technique to Screen for MUC1 Variants
- Anti-C3bBb Autoantibodies in C3 Glomerulopathy
Find the issue here: journals.lww.com/jasn/pages/c...
- Technique to Screen for MUC1 Variants
- Anti-C3bBb Autoantibodies in C3 Glomerulopathy
Find the issue here: journals.lww.com/jasn/pages/c...
February 5, 2025 at 9:54 PM
The February issue of JASN is now available online! Topics covered this month include:
- Technique to Screen for MUC1 Variants
- Anti-C3bBb Autoantibodies in C3 Glomerulopathy
Find the issue here: journals.lww.com/jasn/pages/c...
- Technique to Screen for MUC1 Variants
- Anti-C3bBb Autoantibodies in C3 Glomerulopathy
Find the issue here: journals.lww.com/jasn/pages/c...
Pa nič mu ne bi bilo jasn
September 10, 2026 at 9:27 PM
Pa nič mu ne bi bilo jasn